Clinical Trials Logo

Filter by:
NCT ID: NCT06098508 Recruiting - Clinical trials for Hemiplegic Shoulder Pain

Osteopathic Manual Treatment for Hemiplegic Shoulder Pain and Upper Extremity Function in Stroke Patients

Start date: June 2024
Phase: N/A
Study type: Interventional

This study assesses the feasibility and safety of performing osteopathic manual treatment (OMT) for hemiplegic shoulder pain in stroke patients. This study's participants will be adults with a first-time stroke diagnosis in the past 5 years and shoulder pain on the same side affected by stroke. Eligible participants will be placed on study for approximately 6 weeks and given either OMT or a sham treatment each week.

NCT ID: NCT06098482 Recruiting - Hearing Loss Clinical Trials

An Investigation to Validate Speech Perception Assessment for Adult Cochlear Recipients Using a Mobile Research App

VALDE-MU
Start date: February 5, 2024
Phase: N/A
Study type: Interventional

The study is a feasibility, prospective, repeated-measures, multi-country, multi-centre, study of the Mobile Research App to measure and validate speech perception endpoints in adult cochlear implant recipients.

NCT ID: NCT06098430 Recruiting - Clinical trials for Nodular Lymphocyte-Predominant Hodgkin Lymphoma

Patient-Reported Outcomes and Quality of Life in Adult and Pediatric Patients With Nodular Lymphocyte-Predominant Hodgkin Lymphoma (NLPHL)

Start date: April 4, 2024
Phase:
Study type: Observational

There is a pressing need to measure patient-reported symptoms in patients of all ages diagnosed with nodular lymphocyte-predominant Hodgkin lymphoma (NLPHL). This study aims to measure longitudinal symptom burden and treatment tolerability utilizing validated patient-reported outcomes (PROs) instruments. Primary Objective: - To develop the data collection infrastructure required to prospectively collect longitudinal electronic patient-reported outcomes (PROs) survey instruments in adult and pediatric patients diagnosed with NLPHL. Secondary Objective: - To examine differences in baseline and longitudinal changes in PROs based on disease characteristics, disease status, and treatment strategies among adult and pediatric patients diagnosed with NLPHL.

NCT ID: NCT06098404 Recruiting - Cancer Clinical Trials

Correlates of CRCI and Gut Microbiome Dysbiosis; a Pilot Study

Start date: March 4, 2024
Phase:
Study type: Observational

The aim of this study is to characterize the microbiome and assess fatigue and cognition of patients with cancer undergoing standard of care treatment.

NCT ID: NCT06098352 Completed - Stress Clinical Trials

The Impact of a Continuous Performance Task on the Stress Response

Start date: September 17, 2013
Phase: N/A
Study type: Interventional

The goal of this clinical trial is to learn about the impact of taking a continuous performance attention test on the physiological stress response in college students. The main questions it aims to answer are: - Does taking an attention test cause participants to have increases in heart rate, blood pressure, and sweat? - Does taking an attention test cause participants to have a decrease in heart rate variability? - Are there relationships between participants' levels of anxiety, perceived stress, and mindfulness to their physiological changes? Participants will - Answer questionnaires about anxiety, stress, and mindfulness - Have baseline measurements taken for blood pressure, sweat, and heart rate variability - Take the PEBL Continuous Performance Task (a 14 minute attention test) while having the measurements listed above taken again

NCT ID: NCT06098287 Completed - Asthma Clinical Trials

Residential Ventilation Systems and Filtration for Asthma Control in Adults

Start date: January 1, 2017
Phase: N/A
Study type: Interventional

The goal of this study was to investigate the effectiveness of three common approaches to upgrading residential mechanical ventilation systems in existing homes for improving asthma-related health outcomes, reducing indoor pollutants of both indoor and outdoor origin, and maintaining adequate environmental conditions and ventilation rates in a cohort of adult asthmatics in existing homes in Chicago, IL.

NCT ID: NCT06098183 Recruiting - Clinical trials for Perimenopausal Disorder

Metabolic Effects of Perimenopause

MAAP
Start date: March 22, 2024
Phase: N/A
Study type: Interventional

Starting in early-perimenopause, changes in systemic and tissue level metabolism result in an accelerated loss of muscle mass and an increase in body fat. Our preliminary work indicates that metabolic alterations, specifically a decrease in whole-body protein balance, increase in abdominal adiposity, and reduced metabolic flexibility during exercise is most evident in perimenopause. Exercise is a potent stimulator of skeletal muscle insulin sensitivity. High intensity interval training (HIIT) has been shown to be an effective exercise strategy to support cardiometabolic health in overweight and obese young women. Skeletal muscle is critical to maintaining metabolic health and functionality across the lifespan, and is considered the primary diver of whole-body insulin resistance.There is a significant decrease in muscle mass across the menopause transition, which is often exacerbated by a significant gain in fat mass and visceral fat. Protein consumption prior to HIIT has resulted in improvements in energy expenditure and fat oxidation in young women. The overarching objective of this study is to determine the metabolic response of HIIT compared to traditional aerobic exercise in early and late perimenopausal women. Aim 1 will examine the metabolic responses (glucose, insulin sensitivity, energy expenditure) of HIIT vs aerobic exercise, combined with pre-exercise carbohydrate or protein ingestion, in overweight/obese (BMI: 28-40 Kg/m^2) early and late perimenopausal women. Aim 2 will explore the impact of perimenopause on the fat oxidation and protein turnover before and after exercise. Lastly, aim 3 will explore the modulating effect of intramuscular fat on these metabolic outcomes.

NCT ID: NCT06098170 Active, not recruiting - Clinical trials for Spinal Cord Injuries

Acceptance and Commitment Therapy for Chronic Pain in SCI: Development and Testing of an eHealth Program

Start date: November 15, 2023
Phase: N/A
Study type: Interventional

This study will test the newly-developed My spinal cord injury (SCI) Toolkit program in two formats - unguided use of the program and use supported by a coach. These two active treatment formats will be compared to treatment as usual (waitlist control) in adults with chronic pain and SCI. Hypotheses include: - Treatment adherence, participant satisfaction, and perception of positive change will be high and drop-out rates low for both treatments but will be better in the coached compared to the unguided arm - In terms of pre- to post-treatment changes in pain interference, coached My SCI Toolkit program will be superior to treatment as usual

NCT ID: NCT06098144 Recruiting - Smoking Cessation Clinical Trials

Smoking Cessation Program in the Construction Sector

Start date: April 10, 2024
Phase: Phase 4
Study type: Interventional

The main objective of this study is to identify the optimal adaptive smoking cessation program for the construction sector in terms of effectiveness, cost-effectiveness, and potential implementation.

NCT ID: NCT06098118 Recruiting - Clinical trials for Breast Cancer Screening

Adapting a Mammography Decision Aid to Support Women Living in a Community Contaminated by PFAS

Start date: May 6, 2024
Phase: N/A
Study type: Interventional

This community-engaged research project will test an adapted online breast cancer screening decision aid to address the needs of women living in an area where environmental contamination has increased concern about breast cancer risk. It will provide novel data on individual experiences with breast cancer risk assessment and decisional determinants of screening choices in a community disproportionately impacted by industrial pollution.